Tony Ho
Director/Board Member chez ITEOS THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Le Dr Tony W. Ho est directeur indépendant d'Engrail Therapeutics, Inc. et vice-président exécutif, responsable de la recherche et du développement de CRISPR Therapeutics AG, professeur associé à l'université de Pennsylvanie et professeur adjoint de neurologie à l'université Johns Hopkins. Il siège au conseil d'administration d'iTeos Therapeutics, Inc. et d'Engrail Therapeutics, Inc. Auparavant, le Dr Ho a occupé les postes de vice-président principal et chef de l'oncologie chez Astrazeneca AG, de directeur scientifique chez Neuronyx, Inc. et de chef de Merck Research Laboratories chez Merck & Co, Inc. et de chef de la neurologie et de l'ophtalmologie chez Merck Research Laboratories Massachusetts LLC, ainsi que celui de professeur adjoint à l'hôpital Johns Hopkins, Inc. Il a obtenu son diplôme de premier cycle à l'université de Californie, Los Angeles, et un doctorat à la faculté de médecine de l'université Johns Hopkins.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ITEOS THERAPEUTICS, INC.
-.--% | 13/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Tony Ho
Sociétés | Poste | Début |
---|---|---|
ITEOS THERAPEUTICS, INC. | Director/Board Member | 03/05/2021 |
The Johns Hopkins University | Corporate Officer/Principal | - |
University of Pennsylvania | Corporate Officer/Principal | - |
Engrail Therapeutics, Inc.
Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 29/07/2020 |
Hangzhou Qihan Biotech Co., Ltd.
Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Director/Board Member | 17/10/2022 |
Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd. | Corporate Officer/Principal | - |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Corporate Officer/Principal | 01/03/2022 |
Anciens postes connus de Tony Ho
Sociétés | Poste | Fin |
---|---|---|
CRISPR THERAPEUTICS AG | Chief Tech/Sci/R&D Officer | 14/12/2021 |
Astrazeneca AG | Corporate Officer/Principal | 01/07/2017 |
░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Tony Ho
University of California, Los Angeles | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
CRISPR THERAPEUTICS AG | Health Technology |
ITEOS THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 8 |
---|---|
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Health Technology |
The Johns Hopkins Hospital, Inc.
The Johns Hopkins Hospital, Inc. Hospital/Nursing ManagementHealth Services The Johns Hopkins Hospital, Inc. provides healthcare services. The hospital is affiliated to the Johns Hopkins University School of Medicine. It offers inpatient and outpatient health services that include general medicine, emergency and trauma care, pediatrics, maternity, and senior care. The company was founded in 1889 and is headquartered in Baltimore, MD. | Health Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Astrazeneca AG | |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Finance |
Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd. | Finance |
Hangzhou Qihan Biotech Co., Ltd.
Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Health Services |
Engrail Therapeutics, Inc.
Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |